Study identifier:D8220R00038
ClinicalTrials.gov identifier:NCT05140369
EudraCT identifier:N/A
CTIS identifier:N/A
Observational Retrospective-Prospective Study on CLL Therapy Approaches in Russia.
Chronic Lymphocytic Leukemia
N/A
No
-
All
6000
Observational
18 Years - n/a
Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Sept 2024 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|